Plant-derived medicines are receiving praise from the public, with more people looking for natural alternatives to traditional medication. One European-based pharmaceutical company, MGC Pharmaceutical, strives to increase the availability of these tried and tested high-quality alternative medicines with its natural approach to creating compounded medications using various plant-based ingredients.
The company has an extensive portfolio and is gaining a reputation for being one of the leading biopharma companies in the world. “Our company takes a “Back to Nature” approach, believing that you can find some of the best products for patients in nature. So, not only are we using phytocannabinoid-derived products, but we’re also using other plants from nature in conjunction with various ingredients to bring the latest immune-boosting supplements to patients,” said Roby Zomer, the company’s CEO and co-founder. “What we’re trying to do is expand our patient base, reach a broader audience, and help more people. The way that we plan to make this happen is through clinical trials and additional research on every product we’re producing before it’s available to the public. So, we’re running tests, keeping track of pharmaceutical data, and ultimately working hard to figure out what works and what doesn’t.”
It isn’t the company’s first rodeo. They’ve completed multiple studies and clinical trials on ArtemiC with SwissPharmaCan to learn about its promising effects on patients diagnosed with the Coronavirus. “During clinical trials, we gathered research on dozens of patients and determined that ArtemiC successfully lessened the symptoms associated with COVID-19, thus resulting in healthier patients. In addition, patients participating in the trial who received the natural medication didn’t need hospitalization and typically recovered faster from the symptoms than those without the medication. These were fantastic results to see.“ shared Zomer. “We currently have a growing base of patients in different parts of the world, including the United States, UK, Europe, India, and Australia. However, we’d like to eventually make our immune- boosting supplements readily available to people in as many countries as possible. We believe in what we’re offering because the science and research behind our products provide enough evidence to support the idea of improving patient’s health. We utilize our patented MyCell Technology for almost all of our products natural ingredients which enhance the effectiveness due to higher bioavaliability and bioutilization.”
The success of ArtemiC in patients with COVID-19 inspired the company and its leaders to continue performing research into plant-derived ingredients that help patients achieve optimal results. “If we can help patients recover from illnesses or receive alternative treatments that improve their way of life, we want to make that happen and make a difference for many people. We believe in what we’re offering because we know the public can benefit from these products,” said Zomer. As the company continues to perform research and participate in numerous clinical trials while working alongside other pharmaceutical companies and universities, MGC Pharmaceutical has officially launched its ArtemiC supplements to people in the United States, UK, Europe Union, India and Australia.
